| Website | exogenesis.us |
| Category | BioTech |
| Phone | 978-439-0120 |
| Employees |
| TOTAL | $3.19M |
| VENTURE FUNDING TOTAL | $3.19M |
| Venture Round, 12/10 Inflection Point Ventures Venture Capital Fund of New England JDS Uniphase Corporation | $3.19M |
Exogenesis Corporation engages in developing and processing implantable vascular stents, orthopedic devices, and other medical products utilizing its gas cluster ion beam technology. It offers ClusterCoat Processing System, a room temperature method for modifying the physical and chemical properties of outermost atomic layers of surface while leaving the underlying bulk of the unaffected material. The company was founded in 2005 and is based in Billerica, Massachusetts.
